Biopharma & Life Sciences

Cencora Executive Compensation (FY25)

Name: Cencora (COR) executive compensation
Creator: Velarion
License: https://intel.velarion.ai/terms

COR · Executive and director compensation, fiscal 2022 to 2025

Chief executive, fiscal 2025

◇

Robert Mauch

Latest say-on-pay support

March 5, 2026

Chief executive pay ratio

◇

To the median employee

Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.

See every company’s exec pay — free for 3 days, no card See the plan and pricing

The Cencora brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.

From $500 for the board report; $900 for both.

Get the executive brief Get the board briefNo account needed.

Data as of November 4, 2026Latest filing (8-K): March 6, 2026

12 filings cited on this page

Method: intel.velarion.ai/methodology

A report that fails to generate is refunded in full

Published by Velarion Company Intelligence

Cencora brief$500Get the executive brief

Velarion Intel, one year, every company

322 figures on this page: 314 cited to the filing that reported them, 8 calculated from figures it prints. See the citations

What changed from fiscal 2024 to fiscal 2025

The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.

Chief executive total compensation — Robert Mauch: $9,253,192 → $18,256,227 (97.3% higher)

CEO pay ratio: 210:1 → 198:1 (5.7% lower)

Frequently asked questions

Answers drawn from the data on this page.

Who is Cencora's chief executive and what were they paid?

Robert Mauch was paid $18,256,227 in total compensation as President and Chief Executive Officer for fiscal 2025. Mauch's total moved 97.3% higher from the $9,253,192 reported for fiscal 2024.

What was Cencora's say-on-pay result?

The say-on-pay proposal drew 93.0% of votes cast including abstentions in favor at the meeting held March 5, 2026 for fiscal 2025.

Which companies are in Cencora's peer group?

Companies named in the disclosed peer group include Cardinal Health, Inc., CVS Health Corporation, Eli Lilly and Company, FedEx Corporation and HCA Healthcare, Inc., among others.

What is Cencora's chief executive pay ratio?

The disclosed chief executive pay ratio for fiscal 2025 is 198:1, against median employee compensation of $92,438.

Executive compensation

Every element reported for each named executive officer, by fiscal year.

Fiscal 2022

Officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Steven Collis Chairman, President and Chief Executive Officer	◇	—	◇	—	◇	—	◇	◇
Robert Mauch Executive Vice President and Chief Operating Officer	◇	—	◇	—	◇	—	◇	◇
James Cleary Executive Vice President and Chief Financial Officer	◇	—	◇	—	◇	—	◇	◇
Silvana Battaglia Executive Vice President and Chief Human Resources Officer	◇	—	◇	—	◇	—	◇	◇

Fiscal 2023

Officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Steven Collis Chairman, President and Chief Executive Officer	◇	—	◇	—	◇	—	◇	◇
Robert Mauch Executive Vice President and Chief Operating Officer	◇	—	◇	—	◇	—	◇	◇
James Cleary Executive Vice President and Chief Financial Officer	◇	—	◇	—	◇	—	◇	◇
Elizabeth Campbell Executive Vice President and Chief Legal Officer	◇	—	◇	—	◇	—	◇	◇
Gina Clark Executive Vice President and Chief Communications & Administration Officer	◇	—	◇	—	◇	—	◇	◇
Silvana Battaglia Executive Vice President and Chief Human Resources Officer	◇	—	◇	—	◇	—	◇	◇

Fiscal 2024

Officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Steven Collis Chairman, President and Chief Executive Officer	◇	—	◇	—	◇	—	◇	◇
Robert Mauch Executive Vice President and Chief Operating Officer	◇	—	◇	—	◇	—	◇	◇
James Cleary Executive Vice President and Chief Financial Officer	◇	—	◇	—	◇	—	◇	◇
Elizabeth Campbell Executive Vice President and Chief Legal Officer	◇	—	◇	—	◇	—	◇	◇
Silvana Battaglia Executive Vice President and Chief Human Resources Officer	◇	—	◇	—	◇	—	◇	◇

Fiscal 2025

Officer	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Robert Mauch President and Chief Executive Officer	◇	—	◇	—	◇	—	◇	◇
Steven Collis Executive Chairman	◇	—	◇	—	◇	—	◇	◇
James Cleary Executive Vice President and Chief Financial Officer	◇	—	◇	—	◇	—	◇	◇
Elizabeth Campbell Executive Vice President and Chief Legal Officer	◇	—	◇	—	◇	—	◇	◇
Silvana Battaglia Executive Vice President and Chief Human Resources Officer	◇	—	◇	—	◇	—	◇	◇

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.

Fiscal 2025

Officer	Award	Grant date	Threshold units	Target units	Units granted	Maximum units	Exercise price	Grant date fair value
Elizabeth S. Campbell	RSU	◇	—	—	◇	—	—	◇
Elizabeth S. Campbell	PSU	◇	◇	◇	—	◇	—	◇
James F. Cleary	PSU	◇	◇	◇	—	◇	—	◇
James F. Cleary	RSU	◇	—	—	◇	—	—	◇
Robert P. Mauch	PSU	◇	◇	◇	—	◇	—	◇
Robert P. Mauch	RSU	◇	—	—	◇	—	—	◇
Silvana Battaglia	PSU	◇	◇	◇	—	◇	—	◇
Silvana Battaglia	RSU	◇	—	—	◇	—	—	◇
Steven H. Collis	RSU	◇	—	—	◇	—	—	◇
Steven H. Collis	PSU	◇	◇	◇	—	◇	—	◇

Fiscal 2023, 2024 are included in the PDF.

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.

As disclosed at fiscal 2025 year end

Officer	Award	Unvested units	Market value of unvested units	Exercise price	Expires
Steven Collis	PSU	◇	◇	—	—
	Option	◇	—	◇	11/13/2026
	PSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
Robert Mauch	PSU	◇	◇	—	—
	PSU	◇	◇	—	—
	RSU	◇	◇	—	—
	Option	◇	—	◇	11/13/2026
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
James Cleary	Option	◇	—	◇	11/13/2026
	PSU	◇	◇	—	—
	PSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
Elizabeth Campbell	PSU	◇	◇	—	—
	RSU	◇	◇	—	—
	PSU	◇	◇	—	—
	PSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
Silvana Battaglia	PSU	◇	◇	—	—
	RSU	◇	◇	—	—
	PSU	◇	◇	—	—
	PSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—
	RSU	◇	◇	—	—

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.

Elizabeth Campbell

Executive Vice President and Chief Legal Officer · Employment agreement

Severance multiple	◇
Severance base	◇
Change-in-control multiple	◇
Benefits continuation on change in control	◇
Benefits continuation	◇
Non-compete period	◇
Non-solicit period	◇
Clawback	◇

James Cleary

Executive Vice President and Chief Financial Officer · Employment agreement

Severance multiple	◇
Severance base	◇
Change-in-control multiple	◇
Benefits continuation on change in control	◇
Benefits continuation	◇
Non-compete period	◇
Non-solicit period	◇
Clawback	◇

Robert Mauch

President and Chief Executive Officer · Employment agreement

Severance multiple	◇
Severance base	◇
Change-in-control multiple	◇
Benefits continuation on change in control	◇
Benefits continuation	◇
Non-compete period	◇
Non-solicit period	◇
Clawback	◇

Silvana Battaglia

Executive Vice President and Chief Human Resources Officer · Employment agreement

Severance multiple	◇
Change-in-control multiple	◇
Benefits continuation on change in control	◇
Benefits continuation	◇
Non-compete period	◇
Non-solicit period	◇
Clawback	◇

Steven Collis

Executive Chairman · Employment agreement

Severance multiple	◇
Severance base	◇
Change-in-control multiple	◇
Benefits continuation on change in control	◇
Benefits continuation	◇
Non-compete period	◇
Non-solicit period	◇
Clawback	◇

Director compensation

What each non-employee director was paid.

Fiscal 2025

Director	Fees earned in cash	Stock awards	Option awards	Non-equity incentive	Pension and deferred earnings	All other compensation	Total
Frank K. Clyburn	◇	◇	—	—	—	—	◇
Redonda G. Miller, M.D	◇	◇	—	—	—	—	◇
Werner Baumann	◇	◇	—	—	—	—	◇
D. Mark Durcan Board chair	◇	◇	—	—	—	—	◇
Lauren M. Tyler	◇	◇	—	—	—	—	◇
Dennis M. Nally	◇	◇	—	—	—	—	◇
Lon R. Greenberg	◇	◇	—	—	—	—	◇
Lorence H. Kim, M.D	◇	◇	—	—	—	—	◇
Lori J. Ryerkerk	◇	◇	—	—	—	—	◇
Kathleen W. Hyle	◇	—	—	—	—	—	◇
Richard W. Gochnauer	◇	—	—	—	—	—	◇

Ellen G. Cooper, Ornella Barra, Steven H. Collis and Robert P. Mauch served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.

Earlier years are included in the PDF.

A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.

Board cash retainer	◇
Board equity retainer	◇
Total board retainer	◇
Lead independent director premium	◇
Audit committee chair	◇
Compensation committee chair	◇
Nominating and governance chair	◇

Equity is delivered as restricted stock units.

Stock ownership guideline: 5 times annual cash retainer

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.

Fiscal 2025

Cardinal Health, Inc. CAH
CVS Health Corporation CVS
Eli Lilly and Company LLY
FedEx Corporation FDX
HCA Healthcare, Inc. HCA
Henry Schein, Inc. HSIC
Humana Inc. HUM
IQVIA Holdings Inc. IQV
Labcorp Holdings Inc. LH
McKesson Corporation MCK
Quest Diagnostics Incorporated DGX
Sysco Corporation SYY
Target Corporation TGT
The Cigna Group CI
The Kroger Co. KR
United Parcel Service, Inc. UPS
Viatris Inc. VTRS
Walgreens Boots Alliance, Inc. WBA

Say-on-pay history

Shareholder support for the compensation program, by year.

Year	Meeting	Support	Votes for	Votes against	Abstentions
2025	March 5, 2026	=	◇	◇	◇
2024	March 6, 2025	=	◇	◇	◇
2023	March 12, 2024	=	◇	◇	◇
2022	March 9, 2023	=	◇	◇	◇
2021	March 10, 2022	=	◇	◇	◇
2020	March 11, 2021	=	◇	◇	◇
2019	March 5, 2020	=	◇	◇	◇
2018	February 28, 2019	=	◇	◇	◇

Chief executive pay ratio

As calculated and reported by the company.

Ratio

◇

Median employee compensation

◇

Chief executive total compensation

◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”

- Robert Mauch (President and Chief Executive Officer), FY2025 total compensation $18,256,227 (base salary $1,350,000) [exec_comp, SEC accession 0001628280-26-003061, filed 2026-01-22]

See a complete sample report

What this page does not include

Everything above is a fact Cencora disclosed, and it is free. Everything below is our analysis of those facts, and it is not.

Peer benchmarking

Where Cencora sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.

Executive Compensation Report — $500

Written compensation analysis

A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.

Executive Compensation Report — $500

Board and governance analysis

Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.

Board Governance Report — $500

Realizable pay

What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.

Velarion Intelligence

Adviser switching and vote outcomes

Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.

Inquire about access

Multiple companies at once

Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.

Velarion Intelligence

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.

322 figures on this page: 314 cited to the filing that reported them, 8 calculated from figures it prints.

314 cited to the filing

8 calculated from the filing

Documents cited

8-K, filed March 6, 2026
0001140859-26-000014
Item 2 - Advisory Vote to Approve the Fiscal 2025 Compensation of the Company’s Named Executive Officers.
DEF 14A, filed January 22, 2026
0001628280-26-003061
CEO Pay Ratio · Director compensation · Fiscal 2025 director compensation · Outstanding equity awards at 2025 fiscal year end · and 1 more section
8-K, filed March 10, 2025
0001104659-25-022205
Item 2 - Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers.
DEF 14A, filed January 23, 2025
0001140859-25-000017
Executive Compensation Tables
8-K, filed March 15, 2024
0001104659-24-035043
DEF 14A, filed January 25, 2024
0001104659-24-007747
Summary compensation table
8-K, filed March 15, 2023
0001140859-23-000077
8-K, filed March 15, 2022
0001140859-22-000011
8-K, filed March 16, 2021
0001140859-21-000015
8-K, filed March 9, 2020
0001140859-20-000013
8-K, filed March 5, 2019
0001140859-19-000010
EX-10, filed January 11, 2019
0001140859-19-000002

Cite this data

This page is free to cite. Attribution we ask for:

Velarion, “Cencora executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/COR (accessed 2026).

Short form: data: Velarion

The Cencora brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.

From $500 for the board report; $900 for both.

Get the executive brief Get the board briefNo account needed.

12 filings cited on this page

Method: intel.velarion.ai/methodology

A report that fails to generate is refunded in full

Published by Velarion Company Intelligence

Embed this data

A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.

The headline figures, each with its citation.

<iframe src="https://intel.velarion.ai/comp/COR/embed" width="560" height="480" style="border:1px solid #d8dee8;border-radius:10px" loading="lazy" title="Cencora executive compensation, from Velarion"></iframe>

Connect an AI assistant

Ask your own assistant about Cencora and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

{
  "mcpServers": {
    "velarion": {
      "type": "http",
      "url": "https://api.velarion.ai/mcp"
    }
  }
}

Setup guide and the full list of questions it answers

Biopharma & Life Sciences rankings

Chief executive pay — Biopharma & Life Sciences CEO pay ratio — Biopharma & Life Sciences Say-on-pay support — Biopharma & Life Sciences

Peers Cencora discloses

The companies named in COR's own disclosed peer group.

Cardinal Health, Inc.CVS Health Corporation Eli Lilly and Company FedEx Corporation HCA Healthcare, Inc.Henry Schein, Inc.Humana Inc.IQVIA Holdings Inc.Labcorp Holdings Inc.McKesson Corporation Quest Diagnostics Incorporated Sysco Corporation Target Corporation The Cigna Group The Kroger Co.United Parcel Service, Inc.Viatris Inc.Walgreens Boots Alliance, Inc.

Terms on this page

Say-on-Pay Vote CEO Pay Ratio Median Employee Compensation All companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data

APA

Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854

BibTeX

@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}